Cargando…
Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study
AIMS: There have been no published studies on the safety of magnetic resonance imaging (MRI) at 3 Tesla (3 T) in patients with MRI-conditional implantable cardioverter-defibrillators (ICDs). The aim of this study was to assess clinical safety of the Biotronik ProMRI ICD system during non-diagnostic...
Autores principales: | Zbinden, Rainer, Wollmann, Christian, Brachmann, Johannes, Michaelsen, Jochen, Steinwender, Clemens, Kovoor, Pramesh, Kelle, Sebastian, McGavigan, Andrew D, Ching, Chi Keong, Figtree, Gemma A, Schmidt, Jan, Timmel, Tobias, Lotz, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826205/ https://www.ncbi.nlm.nih.gov/pubmed/31322701 http://dx.doi.org/10.1093/europace/euz189 |
Ejemplares similares
-
Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla
por: Bauer, Wolfgang Rudolf, et al.
Publicado: (2019) -
Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators
por: Pieri, Christopher, et al.
Publicado: (2021) -
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021) -
Implantable cardioverter-defibrillators /
Publicado: (1994) -
N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator
por: Deng, Yu, et al.
Publicado: (2022)